DISCLOSEDQuarterly
Oaktree Capital Management
Indivior Pharmaceuticals Inc · NASDAQ
6,127,212 sh · $251.4M
Filed 30 Jun 2026SEC 13Fview source
Oaktree Capital Management
Indivior Pharmaceuticals Inc · NASDAQ
6,127,212 sh · $251.4M
Bridgewater Associates
Indivior Pharmaceuticals Inc · NASDAQ
37,141 sh · $1.1M
Two Sigma Investments
Indivior Pharmaceuticals Inc · NASDAQ
175,767 sh · $5.4M
Oaktree Capital Management
Indivior Pharmaceuticals Inc · NASDAQ
6,984,102 sh · $212.9M